In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Applied DNA Sciences (APDN), with a price target of $22.00. The company’s shares closed last Thursday at $8.24.
According to TipRanks.com, Chen is a 4-star analyst with an average return of 7.9% and a 36.2% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Currently, the analyst consensus on Applied DNA Sciences is a Moderate Buy with an average price target of $21.50.
See today’s analyst top recommended stocks >>
Based on Applied DNA Sciences’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $552.5K and GAAP net loss of $2.95 million. In comparison, last year the company earned revenue of $2.05 million and had a GAAP net loss of $1.48 million.
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
